Sector Groups

Antimicrobial Resistance (AMR) and Healthcare Associated Infections (HAIS)

Antimicrobial Resistance (AMR) and Healthcare Associated Infections (HAI) are among the biggest global public health challenges of our time. These infections cause significant morbidity and mortality, put pressure on health systems, and incur rising direct and indirect costs.
Medical technologies can help to address these problems by preventing, detecting, monitoring and managing infections and resistance.

Pathogen growth on selective media.

Across the EU, 25,000 people die each year from drug resistant infections[1]. Worldwide, this number will increase to 10 million by 2050[2]. This is 1.8 million more deaths than those attributed to cancer. Not only will this impact patient safety and recovery, but it risks going back to a ‘pre-antibiotic era’, where patients could die from simple bacterial infections and life-saving treatments can no longer be performed safely.

The challenge of AMR is closely linked to HAIs. In fact, HAIs are often caused by resistant bacteria[3], but the occurrence of an infection in the first place can also increase the risk of developing resistant strains.

The effective use of diagnostic tests and medical devices can help to address these challenges by:

  • Preventing and containing healthcare-associated infections and the development and spread of resistant bacteria in healthcare settings to manage antimicrobial resistance.
  • Detecting and identifying bacterial infections and their susceptibility to medication, therefore avoiding the misuse or overuse of antibiotics.
  • Monitoring and tracking resistance and enabling patient compliance to the appropriate use of antibiotics.
  • Outbreak Management and surveillance to track, contain and prevent the spread of pathogens at local, hospital, regional, national and international level.

[1] European Commission: Antimicrobial Resistance http://ec.europa.eu/health/amr/antimicrobial-resistance_en
[2] UK Government Review on Antimicrobial Resistance.https://amr-review.org/
[3] ECDC: AMR and HAIs https://ecdc.europa.eu/en/about-us/who-we-are/disease-programmes/antimicrobial-resistance-and-healthcare-associated

AMR minisite

Click on the link below and find out more about the role of medtech in fighting AMR.

Discover how medtech addresses AMR and HAIs throughout the patient pathway, please visit our blogs

Superbugs: have we built kryptonite on Earth ? Picture

Blog

Superbugs: have we built kryptonite on Earth?

Posted on 08.09.2016

Read more

Superbugs: have we built kryptonite on Earth?

If you experienced heart failure or diabetes, fought HIV, underwent heavy surgery and survived, chances are that antibiotics have already saved your life.

Superbugs: have we built kryptonite on Earth ? Picture

Blog

The superbugs are coming

Posted on 09.02.2016

Read more

The superbugs are coming

Have you ever taken antibiotics for a viral infection? Every time we misuse antibiotics we take another step backwards – undoing decades of medical progress and risking the lives of seriously ill people in our communities.

Related content

Blog AMR & HAIS

Superbugs: have we built kryptonite on Earth?

Posted on 29.10.2018

Read more
Blog AMR & HAIS

The superbugs are coming

Posted on 29.10.2018

Read more